subtop_network
|
|
|
|
|
|
 

Singapore Clinical Research Institute (SCRI)

  • Increase font size
  • Default font size
  • Decrease font size
Home Publications

Publications

  1. Huynh H, Chow PK, Tai WM, Choo SP, Chung AY, Ong HS, et al. Dovitinib demonstrates anti-tumor and anti-metastatic activities in xenograft models of hepatocellular carcinoma. J Hepatol. 2011. Epub 2011/10/27
  2. Chanyaputhipong J, Low SC, Chow PK. Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. International journal of hepatology. 2011;2011:489342. Epub 2011/10/14
  3. Huynh H, Choo SP, Toh HC, Tai WM, Chung AY, Chow PK, et al. Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation. Current cancer drug targets. 2011. Epub 2011/08/13
  4. Tan CH, Thng CH, Low AS, Tan VK, Hartono S, Koh TS, Goh Bk, Cheow PC, Tan YM, Chung AY, Ooi LL, Earnest A, Chow PK. Wash-out of hepatocellular carcinoma: quantitative region of interest analysis on CT. Annals of the Academy of Medicine, Singapore. 2011;40(6):269-75. Epub 2011/07/23
  5. Heng LZ, Ong KW, Chow PK. An unusual case of recurrent obstructive jaundice. Gastroenterology. 2011;140(5):1401, 699. Epub 2011/03/31
  6. Chow PK, Machin D, Chen Y, Zhang X, Win KM, Hoang HH, et al. Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma. Br J Cancer. 2011;105(7):945-52. Epub 2011/08/25.
  7. Lim KC, Chow PK, Allen JC, Chia GS, Lim M, Cheow PC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg. 2011;254(1):108-13. Epub 2011/04/30
  8. Goh BK, Chow PK, Tan YM, Cheow PC, Chung YF, Soo KC, Wong WK, Ooi LL. Validation of five contemporary prognostication systems for primary pancreatic endocrine neoplasms: results from a single institution experience with 61 surgically treated cases. ANZ J Surg. 2011. 81(1-2):79-85.
  9. Lee, SY, Goh BK, Teo, MC, Chew MH, Chow PK, Wong WK, Ooi LL, Soo KC. Retroperitoneal liposarcomas: the experience of a tertiary Asian center. World J Surg Oncol. 2011. 9(1): 12.
  10. Tan VK, Chow PKH. An approach to the ethical evaluation of innovative surgical procedures. Ann Acad Med Singapore. 2011. 40(1): 26-4.
  11. Kao YH, Tan AE, Khoo LS, Lo RH, Chow PK, Goh AS. Hepatic falciform ligament Tc-99m-macroaggregated albumin activity on SPECT/CT prior to Yttrium-90 microsphere radioembolization: prophylactic measures to prevent non-target microsphere localization via patent hepatic falciform arteries. Ann Nucl Med. 2011. Jan 14. [Epub ahead of print].
  12. Kam G, Lee YS, Tan TT, Chow P, and Ng HJ. Surgery-associated acquired haemophilia and response to combined rituximab and cyclosporine treatment. Haemophilia, 2011. Article first published online: 1 MAR 2011
  13. Lim KC, Chow PK, Allen JC, Chia GS, Lim M, Cheow PC, Chung AY, Ooi LL, Tan SB. Microvascular invasion is a better predictor of tumour recurrence and overall survival following surgical resection for HCC compared to the Milan criteria. Annals of Surgery. 2010 (in press Annals of Surgery).
  14. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, and Sarin SK, Asian Pacific Association for the Study of the Liver consensus recommendatins on hepatocellular carcinoma. Hepato Int, 2010. 4(2): p. 439-74.
  15. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, and Lee CG, Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol, 2010. 53(1): p. 57-66.
  16. Ranganath SH, Fu Y, Arifin DY, Kee I, Zheng L, Lee HS, Chow PK, and Wang CH, The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice. Biomaterials, 2010. 31(19): p. 5199-207.
  17. Goh BK, Chow PK, Chok AY, Chan WH, Chung YF, Ong HS, and Wong WK, Impact of the Introduction of Laparoscopic Wedge Resection as a Surgical Option for Suspected Small/Medium-Sized Gastrointestinal Stromal Tumors of the Stomach on Perioperative and Oncologic Outcomes. World J Surg, 2010. 34(8): p. 1847-52.
  18. Jia J, Wang J, Teh M, Sun W, Zhang J, Kee I, Chow PK, Liang RC, Chung MC, and Ge R, Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE. Proteomics, 2010. 10(2): p. 224-34.
  19. Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, Toh HC, Thng CH, Chow P, Ong HS, Chung A, Goh BC, Smith PD, and Soo KC, AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). J Hepatol, 2010. 52(1): p. 79-87.
  20. Goh BKP, Chow PKH, Tan YM, Cheow PC, Chung YFA, Soo KC, Wong WK, and Ooi LLJ, Validation of five contemporary prognostication systems for primary pancreatic endocrine neoplasms: results from a single institution experience with 61 surgically treated cases. ANZ Journal of Surgery, 2010.
  21. Goh BK, *Chow PK, Kesavan SM, Yap WM, Chung YF, and Wong WK, Outcome After Curative Resection of Large (>/=10 cm) Gastric Gastrointestinal Stromal Tumors: How Frequent is Adjacent Organ Involvement and is Concomitant Distal Pancreatectomy Necessary? J Gastrointest Surg, 2010.
  22. Eyles J, Puaux AL, Wang X, Toh B, Prakash C, Hong M, Tan TG, Zheng L, Ong LC, Jin Y, Kato M, Prevost-Blondel A, Chow P, Yang H, and Abastado JP, Tumor cells disseminate early, but immnosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest, 2010. 120(6): p. 2030-9.
  23. Yang S, Ngo VC, Lew GB, Chong LW, Lee SS, Ong WJ, Lam WL, Thng CH, Koong HN, Ong HS, Chung A, Chow P, Lee J, Soo KC, and Huynh H, AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer. Mol Cancer Ther, 2009. 8(9): p. 2537-45.
  24. Samuel M, Chow PK, Chan Shih-Yen E, Machin D, and Soo KC, Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev, 2009(1): p. CD001199.
  25. Ranganath SH, Kee I, Krantz WB, Chow PK, and Wang CH, Hydrogel matrix entrapping PLGA-paclitaxel microspheres: drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy. Pharm Res, 2009. 26(9): p. 2101-14.
  26. Purushotham S, Chang PE, Rumpel H, Kee IH, Ng RT, Chow PK, Tan CK, and Ramanujan RV, Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology, 2009. 20(30): p. 305101.
  27. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, Khin MW, and Koo WH, Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol, 2009. 10(11): p. 1111-8.
  28. Ong LC, Song IC, Jin Y, Kee IH, Siew E, Yu S, Thng CH, Huynh H, and *Chow PK, Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model. Mol Imaging Biol, 2009. 11(5): p. 334-42.
  29. Loa J, Chow P, and Zhang K, Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells. Cancer Chemother Pharmacol, 2009. 63(6): p. 1007-16.
  30. Leong QM, Lai HK, Lo RG, Teo TK, Goh A, and *Chow PK, Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery. J Vasc Interv Radiol, 2009. 20(6): p. 833-6.
  31. Koh V, Goh BK, Ho YH, Goh AS, and *Chow PK, Utility of positron emission tomography/computed tomography in the detection of malignancy within a choledochal cyst. Clin Gastroenterol Hepatol, 2009. 7(4): p. e17-8.
  32. Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, Toh HC, Thng CH, Chow P, Ong HS, Chung A, Goh BC, Smith PD, and Soo KC, AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). J Hepatol, 2009.

Please click here to view the full list of publications